• GenomEra Flu A/B + RSV CE IVD approved and available!


    Abacus Diagnostica´s GenomEra Flu A/B + RSV is now CE IVD approved and available! To discuss more about our new product, come and meet us at ECCMID 2019 in Amsterdam, booth 1.148!


    Analyte                                 PPA (i.e. sensitivity)                        NPA (i.e. specificity)        Accuracy

    Flu A (n=1256)                   97.1%                                                    99.4%                                    98.6%

    Flu B (n=1256)                   100%                                                     100%                                     100%

    RSV (n=701)                        98%                                                        99.8%                                    98.7%

    Overall accuracy:  99.3%

  • Abacus Diagnostica is exhibiting at ECCMID 2019


    Abacus Diagnostica is exhibiting at ECCMID 2019. Contact us to book your meeting with the team to hear the latest news! See you in few weeks at booth #1.148!

  • Abacus Diagnostica at Labquality Days 2019


    Come and meet us at Labquality Days 2019 in Helsinki Conference Centre during 7-8th of February! We will be exhibiting at stand S1 and happy to answer questions concerning our upcoming FLU A/B + RSV.

  • Announcement of new distributors


    We are proud to announce our new distributors as follows:

    • Intuitive Technology Ltd covering Hong Kong and Macau,
    • Medicon Hellas S.A. covering Greece
    • Triolab Baltic OÜ covering Estonia, Lithuania and Latvia
    • HVD Life Sciences covering Israel, Lebanon, Egypt, Jordan, Oman and United Arab Emirates
    • Bergman Diagnostika A/S covering Norway

    Please visit to view the the complete list.

  • Abacus Diagnostica at Medica 2018


                    Meet us at Medica 2018 in Düsseldorf 12-15.11.2018. Please contact to schedule a meeting.

  • Influenza A/B & RSV


    We are completing our new test Influenza A/B & RSV and we will start evaluations during November 2018. If you are interested, please contact us.

  • Abacus Diagnostica at ESCV 2018


    Our CEO Erno Sundberg will be present at the ESCV 2018 event. He will be available during the whole time. Come and collect the latest updates on our influenza A/B & RSV tests.

  • Abacus Diagnostica at ECCMID 2018


    Thank you for all participants who visited us at our booth at ECCMID 2018!

  • Abacus exhibiting at ECCMID 2018 in Madrid!


    Come and meet Erno Sundberg,  Laura Joki and Veikko Wahlroos at Abacus Diagnostica´s stand 20D at ECCMID in Madrid. We will be present during the whole exhibition (21-24.4). See you in a few days!

  • Abacus Diagnostica at Virology Days 8.-9. March 2018


    Meet our team and hear the latest news at Virology Days at Gustavelund, Tuusula, Finland on 8.–9 March 2018.

  • Abacus Diagnostica at Medica 2017


    Erno Sundberg, Laura Joki and Veikko Wahlroos from Abacus Diagnostica will be present at the Medica 2017 exhibition in Düsseldorf 13-16.11.2017. See you there!

  • New brochure for the GenomEra® Norovirus assay


    New brochure for the GenomEra® Norovirus assay is now available and can be downloaded here.

  • Abacus Diagnostica Team participating EMMD


    Abacus Diagnostica team is participating the 10th European Meeting on Molecular Diagnostics (EMMD) with Launch Diagnostics. Come meet us at booth 29!

  • GenomEra® Norovirus Test has received CE mark and is now available!


    Abacus Diagnostica launches worlds fastest molecular test for detection and differentiation of Norovirus genogroups I and II. GenomEra® Norovirus assay has received CE mark for IVD use and is now available for ordering. For more information please visit our Norovirus product page.  For a special introductory offer please contact your local distributor.

  • Evaluation studies for the GenomEra Norovirus assay have started


    We have begun the clinical evaluation studies for our new GenomEra Norovirus assay in three Finnish hospital laboratories. The assay is a direct RT-PCR test for stool samples with less than 2 minutes hands-on-time including only simple sample dilution and heating steps. The assay simultaneously detects and differentiates norovirus genogroups GI and GII with a turnaround time of around one hour. The assay will be available soon for diagnostic use (CE-IVD).

    Human noroviruses, RNA viruses of the family Caliciviridae, are the most common cause of acute gastroenteritis worldwide and cause substantial levels of morbidity and mortality. Symptoms usually include acute onset of vomiting, abdominal cramps and diarrhoea. Noroviruses are also considered to be the most common viral agents of epidemic food-borne and water-borne viral gastroenteritis.

    Interested for evaluation? Contact us or your local distributor.

  • New GenomEra® MRSA/SA AC Test now available!


    GenomEra® MRSA/SA AC Test with the updated mecC detection has now received CE-IVD marking and is available. The test is compatible with both blood cultures and plate colony samples with excellent clinical performance. For more information please visit our MRSA/SA AC product page.

  • Meet us at ScanBalt Forum 2016


    Abacus Diagnostica will be exhibiting at ScanBalt Forum 2016 on the 19th – 20th of October 2016 at Conference Center Mauno in Turku, Finland.

    Come and visit us at our booth.

    For more information on the event visit the event website.

    We hope to see you there!

    Abacus Team

  • New website launched


    The company’s new website has been launched. The site has a redesigned, modern look and it’s now fully mobile device compatible.

  • Excellent results from direct GenomEra GBS swab test


    In addition to current 4 hours and overnight application, Abacus develops a rapid, high performing and cost-efficient diagnostic PCR test for direct GBS swab specimens at the time of delivery.

    Read more